SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 532.78 |
| Enterprise Value ($M) | -106.21 |
| Book Value ($M) | 627.86 |
| Book Value / Share | 10.78 |
| Price / Book | 0.85 |
| NCAV ($M) | 613.60 |
| NCAV / Share | 10.54 |
| Price / NCAV | 0.87 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.23 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.32 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 26.40 |
| Current Ratio | 26.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 639.00 |
| Assets | 653.25 |
| Liabilities | 25.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Biotechnology Value Fund L P | 9.99 | 31.94 | |
| 13G/A | Blue Owl Capital Holdings LP | 3.45 | -41.20 | |
| 13G/A | Vanguard Group Inc | 5.17 | 0.00 | |
| 13G | BlackRock, Inc. | 7.50 | 0.00 | |
| 13G/A | Franklin Resources Inc | |||
| 13G | Flynn James E | 5.71 | ||
| 13G/A | Jovan-Embiricos Morana | 5.09 | -42.46 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 47,454 | 261,879 | 18.12 | |
| 68,481 | 324,233 | 21.12 | |
| 60,413 | 454,907 | 13.28 | |
| 71,513 | 278,697 | 25.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CABA – Cabaletta Bio, Inc. | CCCC – C4 Therapeutics, Inc. |
| CGC – Canopy Growth Corporation | CGON – CG Oncology, Inc. |
| COGT – Cogent Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io